Literature DB >> 31603758

Correlates and Potential Confounds of Cannabis Withdrawal Among High-Risk Adolescents.

Jarrod M Ellingson1,2, L Cinnamon Bidwell1,3, Christian J Hopfer2,4, Kent E Hutchison1,3, Angela D Bryan1,3.   

Abstract

OBJECTIVE: The current study used a sample of high-risk adolescents to examine cannabis withdrawal correlates, including assessments of other drug withdrawal and affective lability that may confound cannabis withdrawal measurement.
METHOD: A total of 448 high-risk adolescents, living in the Southwest United States, were recruited from a juvenile detention center for a sexual risk-reduction intervention study (60% male; 67% Hispanic). Assessments were administered every 3 months for a year, resulting in five assessments of drug use and withdrawal (cannabis, alcohol, nicotine). Affective lability was also assessed.
RESULTS: Forty-two percent of participants endorsed cannabis withdrawal at baseline. Participants used cannabis, on average, 3.3 days/week at baseline and 0.8-1.1 days/week at follow-ups. Cannabis use and withdrawal were only weakly to moderately correlated (r = .14-.32). Unexpectedly, alcohol withdrawal demonstrated strong correlations with cannabis withdrawal at all assessments (r = .41-.55). Furthermore, affective lability measures were related to cannabis withdrawal (r = .22-.32) but not with cannabis use (r = -.03-.09).
CONCLUSIONS: Whereas cannabis withdrawal was only weakly to moderately related to cannabis use, it demonstrated strong associations with alcohol withdrawal across all assessments. In addition, affective lability measures were moderately correlated with cannabis withdrawal but not with cannabis use. Thus, other drug withdrawal and individual differences are essential to consider when assessing cannabis withdrawal.

Entities:  

Mesh:

Year:  2019        PMID: 31603758      PMCID: PMC6811723     

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  40 in total

Review 1.  Are adolescent smokers dependent on nicotine? A review of the evidence.

Authors:  S M Colby; S T Tiffany; S Shiffman; R S Niaura
Journal:  Drug Alcohol Depend       Date:  2000-05-01       Impact factor: 4.492

2.  The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators.

Authors:  Daniela Piontek; Ludwig Kraus; Stéphane Legleye; Gerhard Bühringer
Journal:  Addiction       Date:  2011-03-07       Impact factor: 6.526

Review 3.  Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.

Authors:  Matthijs G Bossong; Raymond J M Niesink
Journal:  Prog Neurobiol       Date:  2010-07-16       Impact factor: 11.685

4.  An investigation of factors related to intoxicated driving behaviors among youth.

Authors:  V Johnson; H R White
Journal:  J Stud Alcohol       Date:  1989-07

5.  Cannabis withdrawal in adolescent treatment seekers.

Authors:  Ryan Vandrey; Alan J Budney; Jody L Kamon; Catherine Stanger
Journal:  Drug Alcohol Depend       Date:  2004-12-18       Impact factor: 4.492

6.  Heavy drinking from the freshman year into early young adulthood: the roles of stress, tension-reduction drinking motives, gender and personality.

Authors:  P C Rutledge; K J Sher
Journal:  J Stud Alcohol       Date:  2001-07

7.  The tobacco withdrawal syndrome in unaided quitters.

Authors:  E R Gritz; C R Carr; A C Marcus
Journal:  Br J Addict       Date:  1991-01

8.  Comparison of extended versus brief treatments for marijuana use.

Authors:  R S Stephens; R A Roffman; L Curtin
Journal:  J Consult Clin Psychol       Date:  2000-10

Review 9.  The cannabis withdrawal syndrome.

Authors:  Alan J Budney; John R Hughes
Journal:  Curr Opin Psychiatry       Date:  2006-05       Impact factor: 4.741

10.  Quantifying the clinical significance of cannabis withdrawal.

Authors:  David J Allsop; Jan Copeland; Melissa M Norberg; Shanlin Fu; Anna Molnar; John Lewis; Alan J Budney
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.